Publications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (21)

2024

  1. Further Evidence of Cerebellar Cognitive Affective/Schmahmann Syndrome in RFC1-Related Syndrome

    Movement Disorders

2023

  1. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  3. Links Between Paraquat and Parkinson’s Disease

    Handbook of Neurotoxicity, Second Edition (Springer International Publishing), pp. 1469-1487

  4. Neuroprotective properties of queen bee acid by autophagy induction

    Cell Biology and Toxicology, Vol. 39, Núm. 3, pp. 751-770

2022

  1. Biological effects of olive oil phenolic compounds on mitochondria

    Molecular and Cellular Oncology, Vol. 9, Núm. 1

  2. In vitro and in vivo models to study the biological and pharmacological properties of queen bee acid (QBA, 10-hydroxy-2-decenoic acid): A systematic review

    Journal of Functional Foods, Vol. 94

2021

  1. The dual role of necrostatin-1 in Parkinson's disease models

    Neural Regeneration Research, Vol. 16, Núm. 10, pp. 2019-2020

2020

  1. Autophagy modulation in animal models of corneal diseases: a systematic review

    Molecular and Cellular Biochemistry, Vol. 474, Núm. 1-2, pp. 41-55

  2. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease

    Aging, Vol. 12, Núm. 17, pp. 16690-16708

  3. Social Cognition in Chiari Malformation Type I: a Preliminary Characterization

    Cerebellum, Vol. 19, Núm. 3, pp. 392-400

  4. Toxicity of necrostatin-1 in Parkinson’s disease models

    Antioxidants, Vol. 9, Núm. 6, pp. 1-13

2019

  1. Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  2. Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-β positivity

    Cortex, Vol. 121, pp. 117-124

  3. Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson’s Disease Patients

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 2466-2481

  4. The paradigm of protein acetylation in Parkinson's disease

    Neural Regeneration Research, Vol. 14, Núm. 6, pp. 975-976

2017

  1. The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice

    Neuropharmacology, Vol. 123, pp. 395-409

2012

  1. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects

    Molecular Psychiatry, Vol. 17, Núm. 6, pp. 612-623

2011

  1. Role of tau protein on neocortical and hippocampal oscillatory patterns

    Hippocampus, Vol. 21, Núm. 8, pp. 827-834

2010

  1. Several factors influenced attrition in a population-based elderly cohort: Neurological disorders in Central Spain Study

    Journal of Clinical Epidemiology, Vol. 63, Núm. 2, pp. 215-222